+ All Categories
Home > Documents > Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Date post: 23-Dec-2015
Category:
Upload: evan-gibson
View: 216 times
Download: 0 times
Share this document with a friend
41
Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami
Transcript
Page 1: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Epidemiological Study Designs And Measures Of Risks

(2)

Dr. Khalid El Tohami

Page 2: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Objectives of the Lecture

• To describe observational study designs

• To describe experimental study designs and clinical trials

• Calculate and interpret of measures of risk

Page 3: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Study designs

Non intervention stud.

(Observational)

Descriptive stud .

Case stud.

Surveys

Analytical stud.

Ecological (correlational)

Cross-sectional (Prevalence)

Case con. Stud. (case-reference)

Cohort stud. (Follow-up)

Intervention stud. (Experimental)

Randomized control Trials (Clinical trials)

Non-randomized trials

(Quasi-experimental study)

Page 4: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Cohort Study

• Cohort study is type of analytical studies.• Distinguishing features:

A. Cohort identified before appearance of disease under investigation.

B. Study groups observed over period of time to determine frequency of the disease.

C. Study proceeds forward from cause to effect.

Page 5: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Concept of cohort:• Cohort in epidemiology defined as a group of

people who share a common characteristic or experience with in defined period time.

• Comparison group may be :• From the general population. Or• Another cohort.

Page 6: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

• Indications of cohort studies:1. In good evidence of association between

exposure &disease.2. If exposure is rare but incidence is high

among exposed.3. If attrition of study population can

minimized.4. When funds are available.

Page 7: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Design of a Cohort Study

Page 8: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Time

Direction of inquiry

population

Disease

No disease

Disease

No disease

People without the

disease

Exposed

Not exposed

Page 9: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Framework of a cohort study

• General consideration to be taken:1. Cohorts must be free from the disease under

study.2. Both groups should be equally susceptible to

the disease under study.3. Both groups should be comparable in all

possible variables.4. Diagnostic &eligibility criteria must be

defined beforehand.

Page 10: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Framework of cohort studyCohort disease

Yes no total

Exposed to putative aetiological factor

A B A+B

Not exposed to the factor

C D C+D

Page 11: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

• After the end of follow up , if• Incidence of disease in exposed (A/(A +B) >

in non-exposed(C/(C+D) this suggest disease & factor are associated.

• Cohort studies are frequently referred to as prospective .

Page 12: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

• TYPES OF COHORT STUDIES

1. PROSPECTIVE COHORT S.2. RETROSPECTIVE COHORT S.3. COMBINATION

Page 13: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

1.Prospective cohort studies:(current)In which outcome has not yet occurred at the time of investigation begins.

2.Retrospective cohort S.(historical)factors occurred before start of investigation.

Page 14: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

3. Combination of retrospective & prospective :• The cohort is identified from past records &

is assessed of date for the outcome. The same cohort is followed up prospectively into future for further assessment of outcome.

Page 15: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

• Elements of a cohort study1. Selection of study subjects.2. Obtaining data on exposure.3. Selection of comparison groups.4. Follow up.5. Analysis.

Page 16: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Analysis of cohort

Factor Disease Total

yes noYes A B A+BNo C D C+D

Among exposed = A/(A+B) Among non- exposed = C/(C+D)

1.Incidence rate

Page 17: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

2. Estimation of risk( outcome ):A. Relative risk.

RR=incidence of outcome in exposed incidence in non- exposedRR measure strength of association.RR>1 mean positive association.

Page 18: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

B. Attributable risk: is the difference in incidence rates between exposed & non-exposed.

AR=I.R(exposed)-I.R(non-exp) *100 I.R(exposed)

Page 19: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Advantages & disadvantages of cohort studies:

• Advantages:1. calculate incidence rate.2. can study several outcomes related to

exposure simultaneously.3. provide direct estimate of relative risk.4. can calculate dose-response ratios.5. can minimized certain bias.

Page 20: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

• Disadvantages:

1. Takes long time.2. Certain administrative problems are

inevitable (loss of fund, experienced s).3. Selection of comparison groups is limiting

factor.4. Changes in standard methods or

diagnostic criteria.

Page 21: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

5. Are expensive.6. Usual lose a substantial proportion of the

original cohort.7. Study may affect people behavior.8. Ethical problems.

Page 22: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Differences between cohort & case – control studies:

Case control study cohort study

1.proceed from ( effect to cause)

Proceed from(cause to effect)

2.starts with disease Starts from risk factor

3.test if suspected cause occur more in diseased than non-diseased.

Test if disease occur more in exposed than non-exposed.

Page 23: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Case control study Cohort study

4.involves fewer number of subjects

Involves large number of subjects

5.relatively get quick results

Long follow up lead to delayed results.

6.suitable for study of rare diseases

Inappropriate in rare diseases or exposure.

7.yields only estimate of RR(odds ratio)

Yields incidence rate, RR as well as AR

8.relatively inexpensive expensive

Page 24: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Experimental Study Designs

In experimental studies the researcher manipulates a situation and measures its effect after that

Type:1- Randomized control trials2- Non-randomized trials

Page 25: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

1) RANDOMIZED CONTROLLED TRIALS

Those trials are used for assessment of methods of treatment and prevention. They include: - intervention - control groups and - randomization

Page 26: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Features of Randomized control trials

1- Manipulation:The researcher does some intervention (Example provision of new drug) to one of the study groups.2- Control:The researcher introduces one or more control groups to compare with the experimental group3- Randomization:Each subject have an equal chance of being allocated to either of the two groups( study and comparison groups)

Page 27: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

steps

1. Drawing a protocol.2. Selecting comparison & experimental groups3. Randomization.4. Manipulation (intervention).5. Follow up.6. Assessment of the outcome.

Page 28: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

RANDOMIZATION

Randomization is the statistical procedure by which the participants are allocated into groups usually called study & control groups to receive or not to receive intervention.

Page 29: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

RANDOMIZATION

Randomization ensures that the investigator has no control over the allocation of the participants to either the study or control group, thus eliminating the selection bias.

Randomization is best done by using statistical random table.

Page 30: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

MANIPULATION Manipulation or intervention is usually done by

application or withdrawal of the suspected factor e.g. drugs, vaccine or dietary factor.

This manipulation creates an independent variable (drug, or new procedure) which effect is then determined by the measurement of the final outcome which is the dependent variable e.g. incidence of disease, recovery.

Page 31: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

FOLLOW UP

This includes examination of the study & control groups subjects at defined intervals of time in standard manner under the same conditions in the same time frame till the final assessment.

The main difficulties in the follow up process include: Attrition from:- death, migration, displacement and loss of interest etc

Page 32: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

ASSESSMENT

The final assessment of the trial is carried in terms of: Positive results: These include the benefits of the experimental study such as reduced incidence of the disease or severity of the disease, cost of health services or other appropriate outcome.

Page 33: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Negative results: These include the severity & frequency of side-effects and complications.

The incidence of positive/negative results is compared in both groups and the differences are tested statistically.

Page 34: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

2 -Non-randomized trials

Page 35: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

a. QUASI-EXPERIMENTAL STUDY DESIGNS

• At least one of the characteristics of the true experiment is missing (RANDOMIZATION OR CONTROL GROUP)

• Example: effect of health education of the level of participation of village population in an immunization campaign.

Page 36: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Blinding .

Blinding is carried in three ways:

1. Single blind trial: The participant is not aware whether he belongs to the study or control group.

Page 37: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

2. Double blind trial: Neither the doctor nor the participant is aware of the group allocation and treatment received.

3. Triple-blind trial: The participant, the investigator& the person analyzing the data are all blind. This is the ideal but double-blinding is the most commonly used.

Page 38: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

DISADVANTAGES OF EXPERIMENTAL STUDIES

• They are costly.• Ethical problems.• Feasibility is difficult.

Page 39: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Summary

• What are the different study designs

• Enumerate measures of the risk

Page 40: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.
Page 41: Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.

Thanks


Recommended